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Catarina Dias1,2, João P. Pais1,2,3, Rafael Nunes 1,2,3, Maria-Teresa Blázquez-Sánchez1,2, Joaquim T. Marquês1,2,
Andreia F. Almeida 1, Patrícia Serra1, Nuno M. Xavier1,2, Diogo Vila-Viçosa1,3, Miguel Machuqueiro 1,3,
Ana S. Viana1,2, Alice Martins1,2, Maria S. Santos1,2, Ana Pelerito4, Ricardo Dias3, Rogério Tenreiro3,
Maria C. Oliveira2, Marialessandra Contino5, Nicola A. Colabufo5,6, Rodrigo F.M. de Almeida1,2 &
Amélia P. Rauter 1,2
Anthrax is an infectious disease caused by Bacillus anthracis, a bioterrorism agent that
develops resistance to clinically used antibiotics. Therefore, alternative mechanisms of
action remain a challenge. Herein, we disclose deoxy glycosides responsible for specific
carbohydrate-phospholipid interactions, causing phosphatidylethanolamine lamellar-to-
inverted hexagonal phase transition and acting over B. anthracis and Bacillus cereus as
potent and selective bactericides. Biological studies of the synthesized compound series
differing in the anomeric atom, glycone configuration and deoxygenation pattern show that
the latter is indeed a key modulator of efficacy and selectivity. Biomolecular simulations show
no tendency to pore formation, whereas differential metabolomics and genomics rule out
proteins as targets. Complete bacteria cell death in 10 min and cellular envelope disruption
corroborate an effect over lipid polymorphism. Biophysical approaches show monolayer and
bilayer reorganization with fast and high permeabilizing activity toward phosphatidyletha-
nolamine membranes. Absence of bacterial resistance further supports this mechanism,
triggering innovation on membrane-targeting antimicrobials.
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Anthrax is an infectious disease affecting livestock andhumans who handle infected farm animals. In addition,this species is a serious bioterrorism threat1,2. All types of
anthrax have the potential, if untreated, to spread throughout the
body causing severe illness and death. Regrettably, therapeutic
options for anthrax are insufficient, relying on long-term, intra-
venous, combined antibiotic treatment with quinolones and tet-
racyclines2. The disease is caused by Bacillus anthracis, a Gram-
positive bacterium that develops resistance to the antibiotics of
choice, namely ciprofloxacin, and examples of new antibacterial
molecules against B. anthracis are scarce3–6. The microbe
genetically closely related to B. anthracis is Bacillus cereus7,
commonly used for research on antimicrobials against B.
anthracis, as it can be manipulated in laboratories of safety level 2
(BSL2). This pathogen is responsible for food poisoning, and for
skin and eye infections, although recently it has drawn more
attention as it has been reported to form biofilms in medical
materials8. This feature is particularly worrisome since biofilm
forming bacteria have increased capacity to survive hospital
environments and implanted medical devices, thriving chronic
wounds, persistent infections and creating a barrier to the
immune system and to antibiotics8.
Our preliminary data on the antimicrobial activity of the sugar-
based surfactants dodecyl 2,6-dideoxy arabino-hexopyranoside
and its 2-deoxy analog, detected by the paper disc diffusion
method over B. cereus, have shown that only the 2,6-dideoxy
glycoside acts as a potent and selective antimicrobial over Bacillus
spp.6. The observed selectivity does not fit the typical behavior of
glucoside surfactants9, also reported as permeability enhancers at
concentrations over 190 μM on human cell lines, allowing sig-
nificant cell recovery due to negligible membrane disruption10.
In this study, we explore the family of deoxy glycosides to
unravel their antibacterial mechanism of action, through gen-
eration by synthesis of a small library of deoxy glycosides and
analogs, structure–activity relationship and mechanistic studies.
Structural features, namely atom linking the dodecyl chain to
the sugar (C–O vs. C–S vs. C–C bond), deoxygenation pattern
(2-deoxy, 4-deoxy, 6-deoxy, 2,6-dideoxy, 4,6-dideoxy), sugar
configuration (arabino, threo, lyxo, and manno), anomeric con-
figuration, and hexopyranoside vs. pentopyranoside structure, are
investigated. The antibacterial profiling and the bioactivity on B.
cereus spore germination are evaluated. Target assessment and
genetic studies are carried out, as well as simulation studies
aiming to rationalize the behavior of deoxy glycosides. Con-
sidering that B. cereus bacterial membrane is rich in phosphati-
dylethanolamine (PE), unlike the outer leaflet of mammalian
cells, which is rich in phosphatidylcholine (PC), biophysical
studies on PE-rich vs. PC-rich membranes are also conducted.
This interdisciplinary approach enabled us to disclose the
mechanism of action of these neutral sugar-based bactericides
targeting membrane PE, and thereby promoting bacterial mem-
brane disruption through phospholipid lamellar-to-inverted
hexagonal phase transition.
Results
Synthesis. A small library of dodecyl deoxy glycosides differing
by the atom (O, S, C) linking the alkyl chain to the glycone,
deoxygenation pattern, anomeric, and glycone configuration
(arabino, threo, lyxo, and manno), and bearing a hexoside/pen-
toside structure is generated by synthesis. Dodecyl 2-deoxy
O- and S-glycosides from both D and L series, namely compounds
2, 4, 7, 8, 17–20 (Fig. 1), are accessed by the proven method
based on reaction of glycals with dodecan-1-ol or dodecane-1-
thiol, catalyzed by triphenylphosphane hydrobromide11,
followed by deprotection (Supplementary Fig 1), also applied to
synthesize compounds 1, 5, 9, and 136. Noteworthy, pentopyr-
anoside 8 adopted, in CDCl3, the unusual 4C1 conformation,
as suggested by nuclear magnetic resonance (NMR) and
rationalized by density functional theory (DFT) calculations
(Supplementary Discussion, Supplementary Figs 2 and 3, and
Supplementary Table 1).
In order to disclose the biological impact of 2-deoxygenation,
6-deoxy-manno enantiomers 6 and 16 (Fig. 1) are prepared
starting from L-rhamnose and D-mannose, respectively, in good
overall yield (Supplementary Fig. 4). Also 4,6-dideoxy-xylo-
hexopyranosides 11 and 12, and their precursor 4-deoxy-xylo-
hexopyranoside 15, are synthesized starting from a 4,6-O-
benzylidene-protected glucopyranoside (Supplementary Fig. 5)
in good overall yield.
Dodecyl 2,6-dideoxy C-glycoside 3 and its enantiomer 10,
along with the 2-deoxy C-hexopyranoside 14 and the C-
pentopyranoside analog 21, are accessed by the approach for
which the key step is the metathesis reaction of allyl α-
C-glycosides. These substrates were prepared via anomeric
allylation12, herein employed on deoxy sugar precursors, to
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Fig. 1 Lead series generated by chemical synthesis. Glycones differ in the deoxygenation pattern (2-deoxy, 4-deoxy, 6-deoxy, 2,6-dideoxy and 4,6-
dideoxy), D- and L-configuration, anomeric configuration, and atom linkage to the dodecyl chain (details on synthesis are given in Supplementary Methods)
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afford allyl α-C-glycosides in good yields. Their reaction with
undec-1-ene in the presence of the second-generation
Grubbs–Hoveyda catalyst (5 mol%) (Supplementary Fig 6),
followed by double bond hydrogenation and Zemplén deacetyla-
tion gave the target molecules in high yield over the three steps.
This efficient methodology opens the way to a diversity of C-
hexopyranosides, which synthesis involves often drastic reaction
conditions.
Susceptibility against B. anthracis and cytotoxicity. Reports on
the mesomorphic behavior of alkyl 2-deoxy-α-D-arabino-hex-
opyranosides and 6-deoxy-β-D-glucopyranosides13,14 encouraged
us to unravel the impact of deoxy glycosides at the biological
level. Their bactericide activity over B. cereus, B. anthracis (Sterne,
pathogenic, and ovine), and Enterococcus faecalis is evaluated
(Table 1). By comparing the bioactivity of hexopyranoside
anomers of D or L series (pairs 1, 5 and 11, 12), it becomes clear
that α-configuration is crucial, corroborating our findings6. The
deoxygenation patterns 6-deoxy, 2,6-dideoxy, and 4,6-dideoxy
conduct to a high antimicrobial activity over all the bacteria
tested, with the most promising result obtained for the 4,6-
dideoxygenated glycoside 11, presenting a minimum inhibitory
concentration (MIC) fourfold lower than its 4-deoxy analog 15.
This tendency is kept for the 2-deoxy/2,6-dideoxy pair 14/10,
whereas compound 13 is not active over B. cereus, as expected,
with a MIC value of 386 µM, also shown for B. anthracis Sterne.
Interestingly, 13 is active over B. anthracis strains ovine and
pathogenic. These out-of-trend results, which are not observed in
all other 2- and 4-deoxy compounds studied, were not expected
due to the genetic similarity of B. anthracis and B. cereus7. In
general, C–C linkage benefits D-series bioactivity, whereas the
relative configuration at C-3 and C-4 does not seem to have any
impact. 2-Hydroxyglycosides 6 and 16 maintain the activity over
B. anthracis Sterne and pathogenic strains, thus inferring that in
hexopyranosides C-6 deoxygenation is crucial for activity over
B. cereus and B. anthracis Sterne. MIC values over E. faecalis are
mostly above 48 μM.
Compound cytotoxicity is assessed by evaluating the effect on
Caco-2 cell viability by the MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide] assay (Table 1, Supplementary
Fig 7). C-glycosides 3, 10, and 21, and α-pentopyranosides 7 and
17 are the less toxic tested compounds, whereas 4,6-dideoxy
glycoside 11 shows the highest selectivity for all tested bacteria vs.
eukaryotic cells.
Bactericidal activity and antimicrobial resistance. Time-kill
studies of B. cereus ATCC 14579 are performed to assess glyco-
side 1 bacteriostatic or bactericidal activity, in parallel to the
generation of its analog library of compounds. The broth
microdilution method according to Clinical and Laboratory
Standards Institute (CLSI) guidelines15 is chosen for the simul-
taneous data assessment by varying multiple experimental con-
ditions, but the MIC values obtained are twofold higher than
those above disclosed for the agar dilution method. The time-kill
assay is accomplished with a temporal resolution of 10 min, the
minimal time required for sampling, at the concentrations of
4–32 µg mL−1 (Supplementary Fig 8, Supplementary Table 2).
Although the resolution is far superior to the traditional method
collecting results hourly, at 106 starting cell concentration the
kinetics of bacterial cell death cannot be detected at 16 µg mL−1
compound concentration or higher, due to complete cell death,
observed at the first temporal point. Still, a 1000-fold reduction
(T99.9) is reached within 60 min for initial bacterial load of 107
and 108 CFUmL−1. No significant bacterial cell death is observed
at 4 and 8 µg mL−1 in comparison with controls. In all performed
assays, MIC equal to minimum bactericidal concentration (MBC)
values indicates bactericidal activity (Supplementary Table 3).
The extremely fast bacterial death is also pointing towards a
biophysical action at the cellular envelope.
Table 1 Antibacterial activitya expressed in MICs and cytotoxicity over Caco-2 cells expressed in IC50 (MTT assay)
Compound Nr MIC (µM) Cytotoxicity IC50 (µM)
B. anthracis E. faecalis B. cereus 24 h 48 h
Sterne Pathogenic Ovine
1 25 25 25 50 25 100 > 50
2 24 48 48 > 48 48 > 50 > 50
3 27 54 54 > 54 27 > 100 100
4 25 25 25 > 50 25 100 50
5 202 101 101 101 202 n.d. n.d.
6 24 24 48 48 n.d. n.d. n.d.
7 26 52 52 52 n.d > 100 100
8 26 26 52 52 n.d. n.d. n.d.
9 50 50 50 50 25 100 50
10 27 27 27 > 54 27 > 100 > 100
11 12.6 12.6 12.6 12.6 12.6 n.d. 50
12 > 405 > 405 > 405 > 405 > 405 n.d. 50
13 386 12.0 12.0 12.0 386 100 > 50
14 104 51 51 51 51 n.d. n.d.
15 51 51 51 51 51 n.d. n.d.
16 24 24 > 48 > 48 48 n.d. n.d.
17 26 52 52 > 52 52 > 100 > 100
18 26 26 52 52 52 > 100 > 50
19 50 25 50 50 25 n.d. n.d.
20 25 50 50 > 50 50 n.d. n.d.
21 28 28 28 56 28 > 100 100
Ref.b 25 25 25 19 19 n.d. n.d.
aMüller–Hinton agar dilution method following CLSI guidelines15. bChloramphenicol
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The effect of compound 1 on B. cereus cells is also monitored
by ex-situ atomic force microscopy (AFM) (Fig. 2). Three-
dimensional topographic images clearly show the typical rod-
shape expected for B. cereus and the complete loss of cellular
integrity at MIC value. At sub-inhibitory concentrations, cellular
damage by the presence of cracks and discontinuities at the
cellular envelope is detected, in line with the bactericidal action of
glycoside 1 by direct interaction with the cell envelope of B.
cereus.
Resistance development, through natural mutagenesis, is
assessed by submitting B. cereus to serial passage on gradient
concentration of compound 1. No alteration of MIC and MBC
values is observed after 15 daily serial passages. Moreover,
compound 1 antibacterial activity remains the same over B. cereus
strains resistant to the main classes of known antibiotics
(Supplementary Table 4), demonstrating that its mechanism of
action is not related to that of those drugs and the mechanisms of
resistance do not compromise compound activity. These findings
show that this type of structures does not face the earlier
emergence of bacterial resistance.
Metabolomics, genetics, and ultrastructural studies. Differential
metabolomics analysis is carried out for detection of eventual
interaction of compound 1 with cellular subsystems. By using
Phenotype MicroArray-based approach16,17, the differential
analysis of B. cereus ATCC 14579 metabolism shows selective
inhibition to several carbon sources. The associated metabolic
pathways are identified according to the KEGG (Kyoto Ency-
clopedia of Genes and Genomes) database and hierarchical
mapped (Supplementary Fig 9). Several clusters are identified,
yielding as main targets the environmental information proces-
sing systems, namely ABC transport systems and
phosphotransferases (PTS). Given the surfactant properties of
these glycosides, differentiation between specific vs. non-specific
mode of action can only be done by exclusion, since the surfac-
tant effect is present. Hence, a genetic dissection for protein target
assessment is carried out. A mutant library is created by random
transposition, using B. cereus ATCC 14579 as isogenic system and
its susceptibility to compound 1 is evaluated. MIC values remain
unchanged when compared with the parental strain, indicating
the absence of any resistance to the test compound, although a
high number of mutants is obtained. In parallel, a library of
specific knockout mutants for the several ABC and PTS systems
previously identified as putative targets are challenged with
compound 1 (Supplementary Table 5). Again, no difference
between MIC values is observed in comparison with parental
strain. These results suggest the absence of proteins as specific
targets.
Aiming to understand the role of cellular envelope ultra-
structure, protoplasts of B. cereus, Staphylococcus aureus, and
spheroplasts of Escherichia coli K12 are submitted to the action of
compound 1 (Fig. 3). The external cell wall of Gram-positive
bacteria is not relevant since MIC values for bacteria and
protoplasts are the same. E. coli spheroplast and B. cereus
protoplast, containing 85% and 43% PE, respectively18, have high
susceptibility to 1 (Fig. 3, Supplementary Table 6), whereas no
activity is found over S. aureus (PE ca. 0%), indicating that
cytoplasmic membrane composition is crucial for activity. This
phospholipid has also been detected in the composition of wild-
type B. anthracis Sterne strain but it was not quantified19. It is
assumed to be similar to that of B. cereus18, to which it is closely
related genetically7.
E. faecalis, showing minor susceptibility, contains other
zwitterionic lipids and unusual uncharged lipids in the cytoplas-
mic membrane, with biophysical properties different from those
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Fig. 2 TappingTM mode AFM imaging of B. cereus deposited on mica surface. a, d Depictions of B. cereus before the exposure of compound 1, whereas b, c,
and e show the bacteria in the presence of compound 1. a–c 3D representations of topographic images, whereas d and e (scale bars= 750 nm) are detailed
topographic (left panels) and phase-contrast (right panels) images of untreated cells and upon interaction with glycoside 1 (8 μg mL−1), respectively. The
arrows indicate lesions in the cellular envelope
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of the anionic lipids (e.g., cardiolipin, CL). In the presence of
cationic bactericides, E. faecalis behaved similarly to Gram-
positive bacteria with high PE content, but the mechanism of
action was unknown18.
Compound effect on spore germination is also evaluated.
When spore coat is cracked and bacterial cell membrane becomes
accessible, bactericidal effect occurs (Supplementary Table 7,
Supplementary Fig 10) and the spore becomes unavailable for
future germination. So far, results point to a mechanism of action
driven by interactions with bacterial cytoplasmic membrane.
In silico studies on membrane destabilization. Given the key
role of cell membrane on bactericidal action, in silico studies on
membrane destabilization by molecular dynamics (MD) simula-
tions are carried out with a 1,2-dimyristoyl-sn-glycero-3-phos-
phocholine (DMPC) bilayer. Even though PC lipids are only
common in eukaryotes and virtually absent in Bacillus mem-
branes, they are the most reliable model system for biomolecular
simulations of lipid bilayers20. In the context of surface-active
drugs, a widespread mode of action is based on transmembrane
pore formation21. Pore morphological complexity and size, and
formation kinetics make it challenging to characterize such sys-
tems by conventional MD simulations22–25. In addition, it has
been reported that the surface tension (ST) has an impact on the
size and stability of preformed transmembrane pores26,27. Herein,
an approach based on the effect of compound 1 on the stability of
pre-formed membrane pores under different ST values is devised.
Systems featuring a large pore size and different number of gly-
coside molecules (0%, ~ 20 mol%, or ~ 50 mol% of compound 1)
in the two-component bilayer are obtained following an equili-
bration procedure. The stability of the pre-formed pores is eval-
uated by monitoring the size of the transmembrane water cavity
throughout the simulations without external ST (Fig. 4 and
Supplementary Fig 11), and pore closure is observed after a few
tens of nanoseconds. Interestingly, by increasing the molar ratio
of compound 1, pore closure occurs in shorter timescales, sug-
gesting that its neutral head group, being less polar than DMPC
zwitterion, is not able to stabilize high-energy water molecules in
the pore region, in contrast to other membrane-active drugs21.
This observation holds when an increasing ST is applied in our
systems (Supplementary Fig 12) and, as expected, at higher ST
values the pore closure kinetics are slower. Only at unphysical
high ST conditions, which cannot be related to the bacterial cell
level, the significant pore enlargement and membrane disruption
are observed.
Deoxy glycoside impact on membrane structural properties is
investigated by simulations of a series of glycoside-DMPC binary
mixtures in a hydrated bilayer environment (glycosides 1, 6, and
7), as well as octyl β-D-glucopyranoside (OG) and dodecyl β-D-
glucopyranoside (DG), both exhibiting detergent properties28,29,
which effect on model PC membrane systems has been
experimentally investigated30 (Fig. 5, Supplementary Figs 13-
18). To evaluate their effect on phospholipid acyl chain ordering,
we compute the deuterium order parameters |SCD| (Fig. 5,
Supplementary Figs 14 and 15). Glycosides 1, 6, and 7 promote
an ordering of phospholipid acyl chains, this effect being slightly
more pronounced for glycosides featuring less hydrophilic
headgroups (Fig. 5a), whereas binary mixtures with OG or DG
show a different behavior, e.g., addition of DG to the bilayer has
only a negligible effect on DMPC acyl chains whereas increasing
OG molar fractions promotes a decrease in DMPC acyl chain
ordering (Fig. 5b), in reasonable agreement with the literature30.
Incorporation of increasing concentrations of deoxy glycosides
also promotes a thickening of the membrane (Supplementary
Fig 16), with the glycoside headgroups populating outer regions
of the bilayer (Supplementary Figs 17 and 18). Therefore, the
results clearly show a different behavior for the deoxy glycosides
when compared with alkyl glucoside detergents and highlight that
sugar deoxygenation modulates the effect of these molecules over
a lipid bilayer mimicking human cell membrane, thus giving
molecular insights into the low toxicity observed in Caco-2 cells.
Interaction of alkyl deoxy glycosides with PE bilayers. In the
quest for deoxy glycoside mode of action, the crucial findings rely
on the selectivity for Bacillus spp., cytoplasmic membrane com-
position, and the absence of specific protein targets, converging
into a phospholipid molecular target, as cell membranes with
exposed PE showed the highest susceptibility. A unique biophy-
sical feature of PE is its propensity to adopt an inverted hexagonal
(HII) phase while PC lipids form the most stable bilayer (lamellar)
phases, namely the fluid Lα phase. Progressive increase of stress in
membrane curvature resulting from Lα to HII phase transition can
induce structural defects in membrane morphology, increased
permeability, and, eventually, loss of integrity. In vivo, these
processes can lead to cell death31. To understand the key role of
PE, glycosides 1 and 13, both with similar surface activity6 but
with contrasting antimicrobial activity over B. cereus (Table 1),
are investigated. Interaction with PE bilayers is first detected by
monitoring turbidity changes at 450 nm induced by these glyco-
sides in PE large unilamellar vesicles (LUVs). Both compounds
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Fig. 3 Effect of 1 in Gram-positive bacteria/protoplasts and in Gram-negative bacteria/spheroplasts. Phosphatidylethanolamine (PE)—depicted in gray;
phosphatidylglycerol (PG)—depicted in light blue; cardiolipin (CL)—depicted in dark blue
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06488-4 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4857 | DOI: 10.1038/s41467-018-06488-4 |www.nature.com/naturecommunications 5
induce a concentration-dependent turbidity increase, reflecting
that significant membrane interaction with the compounds can
be easily detected in the range of concentrations where the most
promising agents are active. The two compounds studied show
completely different trends, pointing to different interaction
modes (Fig. 6a). PE lamellar to hexagonal phase transition is then
examined by a well-established method, the temperature depen-
dence of the steady-state fluorescence anisotropy of an appro-
priate probe incorporated in PE liposomes32,33. This method is
chosen among other major techniques to study lipid poly-
morphism, because it allows to carry out the experiment in
conditions close to physiological34, using compound:lipid ratios
and absolute compound concentration that can be directly related
to those that correspond to the biological studies described above
in this study. In order to select an appropriate probe, controls are
performed with multilamellar vesicles (MLVs) composed exclu-
sively of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE). Three probes already reported in the literature as
detectors of phase transition are tested: 1,2-dipalmitoyl-sn-gly-
cero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-
yl) (NBD-DPPE)35, 1,2-dimyristoyl-sn-glycero-3-phosphoetha-
nolamine-N-(lissamine rhodamine B sulfonyl) (Rh-PE)35,36, and
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-
toluenesulfonate (TMA-DPH)33. Rh-PE and TMA-DPH detect
the lamellar to hexagonal phase transition at 71 °C, in agreement
with hexagonal phase transition temperature (TH) values reported
in the literature35–37. In both cases, TH is observed as a minimum
on the thermotropic dependence of fluorescence anisotropy curve
where, in the first place, anisotropy decreases reflecting the
increase of the motional freedom of the probe in the lamellar
phase, abruptly increasing after the transition to HII35. TMA-
DPH is selected for subsequent studies, as it yields better defined
curves and more precise TH values (Supplementary Figs 19 and
20). Moreover, the fluorescence anisotropy of TMA-DPH also
reports on the PE order at the level of the ester/first acyl chain
methyl groups, giving precious information on the effects of the
compounds on the organization of the bilayer in the Lα phase and
thus a deeper understanding on the biophysical mechanism
behind their action.
By using MLVs composed of POPE/Soy:PE 3:1 mol:mol, the
fluorescence anisotropy of the TMA-DPH probe over a
temperature range of 24–44 °C demonstrates a parabolic profile
with a well-defined minimum at 35.3 ± 0.6 °C (Fig. 6), corre-
sponding to the lamellar to TH. Identical MLVs suspensions
containing compound 1 or 13 (50 μM) are also tested and
compared (Fig. 6). For temperatures preceding TH, the presence
of compound 1 leads to a decrease in fluorescence anisotropy
values when compared with those observed for both control and
compound 13, reflecting a decrease in the order of the lipid
matrix, as opposed to compound effect on bilayers of the human
cell abundant PC, a phospholipid without tendency to form
hexagonal phases. On the other hand, compound 13 seems to
induce order in the vesicles, when compared to the control.
Moreover, although this compound does not affect TH of the PE
binary mixture (TH= 35.2 ± 1.1 °C), compound 1 clearly
decreases TH (TH= 32.2 ± 0.8 °C), increasing the propensity of
PE mixture to reorganize into a hexagonal phase. This
observation also corroborates the different trends of turbidity
and distinct mechanisms underlying membrane interactions with
each compound. These assays complement each other as turbidity
changes reflect the behavior of liposomes upon increasing
glycoside concentration, whereas in the fluorescence anisotropy
test the glycoside is previously incorporated in the liposomes, at
the highest concentration tested.
A membrane passive permeability assay is chosen to directly
assess both the ability of compounds 1 and 13 to interact with
POPE vs. POPC bilayers, and to evaluate their membrane
permeabilizing activity toward these two different glyceropho-
spholipids. LUVs suspensions with encapsulated carboxyfluor-
escein at a high concentration (40 mM) will have very low
fluorescence intensity due to self-quenching. As it crosses the
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Fig. 4 Effect of compound 1 on the stability of pre-formed membrane pores.
a Estimated size of pre-formed membrane pores over time without external
surface tension. The five replicates of each system, namely pure DMPC
(control) and mixtures containing ~ 20% or 50% of compound 1 are
presented. A full pore corresponds to a region with ~ 1800 water molecules
between leaflets. The gray region represents very small pore sizes and, in
many cases, complete closure of the pore. Pore size was estimated using
the number of water molecules in the interior of the transmembrane cavity.
The data are shown as a floating window average (2 ns) for clarity. A
graphical representation of b a large pore and c a small pore is also shown
for a 20% molar ratio mixture. DMPC molecules are shown as thin lines
while those of compound 1 are shown as thicker sticks. Water molecules
and phosphorus atoms are shown as blue and orange spheres, respectively
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lipid membrane, carboxyfluorescein will be at very low concen-
tration in the outer buffer and, consequently, will be relieved from
fluorescence self-quenching. As a result, the kinetics of leakage
can be monitored as an increase of fluorescence intensity over
time. These membrane permeability curves are shown in Fig. 7a.
From the results obtained for the membrane passive permeability
it is clear that compound 1 is the most active one, and that POPE
membranes are extremely susceptible to this compound, which
induces a complete release (~ 100 % of leakage) of encapsulated
carboxyfluorescein, whereas compound 13 only seems to slightly
perturb the membrane. In this case, only ~ 10 % leakage is
obtained (see also Fig. 7b). Such results show that compounds 1
and 13 interact with the POPE membrane differently. Although
compound 13 seems to promote a minor perturbation of
membrane organization, compound 1 leads to a more drastic
reorganization of the lipid membrane with the concomitant full
release of carboxyfluorescein, in very good agreement with the
previous results. Moreover, POPC LUVs are more resilient than
POPE liposomes to the action of compound 1, as a total
membrane leakage of ~ 30 % is observed for POPC membranes
during the course of the experiment in opposition to the ~ 100 %
of leakage for POPE liposomes. Even the Lmax value obtained
from the fit (Fig. 7b) is < 50% for POPC. These results strongly
suggest that compound 1 interacts differently with PC or PE
membranes. The low permeabilizing activity in PC bilayers seems
to be in good agreement with the results of the MD simulations.
The formation of pores owing to the localized transition from
lamellar to an inverted hexagonal-like phase in POPE membranes
(or at least of high-curvature stress areas) as a result of the
interaction with compound 1 would have as outcome the
complete release of carboxyfluorescein. On the other hand, all
other situations where an incomplete release of carboxyfluor-
escein is obtained, surely, do not involve a lamellar-to-hexagonal
phase transition or a high-curvature stress, but most probably
only a smaller perturbation on the packing of the lipids within the
bilayer. The presence of 1.2 % (v/v) of ethanol only leads to a
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negligible leakage (1–2 %) during the course of the experiment
(14 h).
From the analysis of the permeability curves the time of
leakage, τL, is also obtained (Fig. 7c). The fastest process is the
permeabilization of POPE by 1 (τL of about 160 min), whereas the
slowest activity is also for compound 1, but when added to POPC
(τL of about 692 min). Thus, the interaction of 1 is much faster
with PE bilayers than PC, suggesting a higher affinity for the PE
bilayer. On another hand, compound 13 has intermediate values
of τL that are not markedly different for both lipid bilayers, of
about 326 min for POPE and 256 min for POPC. Thus, the speed
of interaction of this compound (and thus possibly its affinity) is
similar for both lipids. Both compounds have a hydrophobic
dodecyl chain, so it is expected that they present some interaction
with both glycerophospholipid bilayers. Overall, these results
strongly support that 1 but not 13 has higher affinity for PE than
PC, and also that the mode of action of 1 behind its antimicrobial
activity toward microorganisms with high levels of exposed PE
indeed involves its specific interaction with PE leading to
membrane permeabilization.
To further support the distinctive interaction of compound 1
with PE, surface pressure (π) measurements are carried out using
a Langmuir trough. The effect of compounds 1 and 13 on the
compression isotherm of POPE molecules at the air/water
interface is assessed (Fig. 8a, b). Compression isotherms of POPE
alone show a liquid expanded–liquid condensed transition
around 37 mNm−1 and collapse upon reaching surface pressures
of ~ 54 mNm−1, which is in good agreement with other reports
from literature38,39. However, the compression curves recorded
after injection of compound 1 (Fig. 8b) show a clear shift to the
left, i.e., lower mean molecular area per lipid (A/lipid) values. To
attain the same A/lipid, the difference (drop in this case) in π can
be as high as 15 mNm−1. Such shift may be a consequence of
altered packing properties of the POPE monolayer and/or a lesser
number of POPE molecules available for the formation of the
monolayer. The local action of compound 1 may trigger the
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increase of monolayer curvature, possibly with the formation of
invaginations. These per se can justify the shift of the curves
toward lower π-values. If a fraction of the POPE molecules in
these high-curvature areas undergoes a lamellar-to-hexagonal
phase transition, they no longer reside at the air–water interface
plane, as they will tend to aggregate and possibly precipitate. In
opposition, compression isotherms of POPE recorded after the
incubation with compound 13 (Fig. 8a) exhibit a slight shift to the
right, i.e., higher A/lipid molecule values. This observation is
consistent with the insertion/incorporation of compound 13 into
the lipid membrane without triggering any remarkable membrane
reorganization. Moreover, preformed POPE monolayers at ~ 25
mNm−1 are incubated either with compounds 1 or 13 and the
variation in π is monitored over time until equilibration, i.e., the
interaction/incorporation of the compounds on the PE mono-
layer is followed over time (inset in Fig. 8a). Notably, the addition
of compound 1 at a concentration as small as 0.2 µM leads to a
marked decreased in π of almost 3 mNm−1, especially when
compared with the effect of compound 13 at the same
concentration, which is unable to promote any obvious change
in the final π-value. Such a large effect for this concentration
range denotes a specific/high-affinity interaction between the
antimicrobial agent with the lipid molecules rather than a general
interaction of an amphiphilic compound, such as a fatty acid or a
fatty acid derivative, with the lipid monolayer40–42. Changes
induced by compound 13 are < 0.5 mNm−1 and after equilibra-
tion π returns to its initial value.
Compression isotherms of pure POPC monolayers, contrary to
POPE monolayer, reveal that POPC remains in the liquid
expanded phase during all compression cycle, and that it collapses
around 44 mNm−1, which is in fine agreement with
literature39,43. Compression isotherms of POPC monolayers
(Fig. 8c) before and after injection of compound 1 also support
a unique interaction between the compound and POPE. As
mentioned, upon the incubation of POPE monolayers with
compound 1 the compression curves are clearly shifted to lower
A/lipid. However, in what concerns POPC, the curves obtained
after incubation with compound 1 are practically superimposed
with those acquired in the absence of this compound. Although
cell membranes are more complex than liposomes, these results
point to structural tendencies of lipids while interacting with
glycoside 1 and support the distinct behavior of compounds 1
and 13 against B. cereus. The bioactivity relates to PE
reorganization thereby promoting lamellar to hexagonal phase
transition, which emerges as the mechanism underlying mem-
brane disruption and bactericidal activity of compound 1 over B.
cereus. The lack of activity of 13 over B. cereus is consistent with
the biophysical studies herein presented. Worth mentioning, PE
constitutes only 23% of mammalian plasma membrane phos-
pholipids, and is mostly confined to the inner monolayer44,45,
therefore not directly accessible to the antimicrobial agent,
highlighting the importance of this mode of action with
therapeutic potential. In general, it is assumed that membrane
interactions involving charge neutralization have an important
role in antimicrobial peptides (AMPs) mode of action, as many of
these peptides are cationic or present a highly cationic surface
that promotes binding to bacterial membrane anionic phospho-
lipids, such as lipopolysaccharides, phosphatidylglycerol, or CL45–
47. However, cinnamycin, a peptide that targets PE through a very
strong binding, while presenting very weak binding to PC
membranes, has net formal charge zero at physiological
pH46,48,49. In agreement, our active compound, bearing no
charge, also targets PE. A literature survey on the antimicrobial
susceptibility of B. cereus (ATCC 14579) (reviewed in Supple-
mentary Table 8) shows that most bactericides reported belong to
the traditional classes of antibiotics, such as penicillins,
amphenicols, fluoroquinolones, and rifamycins50–56. However,
these classes now face substantial resistance problems to a
number of bacteria and research on alternative solutions is not
ubiquitous. Although B. cereus (ATCC 14579) has been reported
to be susceptible to membrane-targeting agents, such as
polymyxin B54 and daptomycin55, which act by membrane
permeabilization and depolarization, their MICs are disappoint-
ingly high and present high host toxicity. In addition, these AMPs
have considerable limitations, such as low in vivo stability due to
degradation by proteases, extensive serum binding, and loss of
antimicrobial activity in the presence of physiological concentra-
tion of salts57, characteristic of peptide drugs. The antimicrobial
lead series herein discussed and the mode of action relying on PE
binding represents a significant step toward antimicrobials with
new mechanisms of action.
Discussion
One aspect that makes targeting cell membrane so appealing is its
essentiality, which does not depend on the metabolic state of the
cell. Unfortunately, chemotypes with bacterial membrane dis-
ruption properties are often disregarded due to concerns over
selectivity. In our view, and others58, membrane-targeting anti-
biotics have been underexploited. The well-known differences
between eukaryotic and prokaryotic cell membrane composition
encouraged us to search for leads selectively interacting with
prokaryotic cell membranes, succeeding with the development of
the present family of dodecyl deoxy glycosides. The glycone
conducting to the highest bactericide activity over B. anthracis
strains and B. cereus with low toxicity and selectivity over pro-
karyotics is that of dodecyl 4,6-dideoxy-α-D-xylo-hexopyranoside
(11) but deoxy C-glycosides of D-series with α-configuration
should also be highlighted regarding activity and toxicity. By
having a determinant role in PE-rich membrane interaction,
bacteria resistance to these bactericides is avoided, as cell envel-
ope ultrastructures cannot easily change without substantial loss
of function. In summary, we set forth a creative approach relying
on a multidisciplinary strategy and covering chemistry, biology,
and biophysics, which led to the discovery of sugar-based anti-
microbials acting over PE-rich membrane microbes by targeting
membrane lipid polymorphism.
Methods
Chemical synthesis. Reactions were conducted under nitrogen using dried
solvents, unless otherwise stated, and monitored by thin-layer chromatography
carried out on silica-coated aluminum foil plates (visualized by UV or 10% H2SO4
in MeOH). Compounds were purified by column chromatography and their
structural characterization was accessed by NMR and high-resolution mass
spectrometry analyses. Specific NMR assignements were determined by
multidimensional and decoupling experiments. 1H and 13C NMR spectra for
final compounds are provided in Supplementary Figs 21–39. Detailed procedures
and full characterization of all compounds are available in Supplementary
Methods.
Antimicrobial assays and bacterial strains. For results presented in Table 1, the
broth microdilution method on Müller–Hinton medium was employed to deter-
mine the MICs, according to the CLSI guidelines15. Three strains of B. anthracis
(pathogenic strain—a human isolate, ovine strain—an animal isolate, and Sterne
strain, all three from the biobank of the National Health Institute Doutor Ricardo
Jorge (INSA), confirmed as B. anthracis strains by real-time PCR and biochemical
tests), B. cereus (ATCC 10876), and E. faecalis (ATCC 29212) were used. Com-
pounds were incubated with bacteria for 16 h at 37 °C before determining the MIC,
which is defined as the lowest concentration of the tested compounds at which no
bacterial growth was observed. For all biological studies described below, the strains
used were B. cereus ATCC 14579 and/or S. aureus ATCC 25923, unless otherwise
stated. For determination of bactericidal activity, MICs were determined by a
modified microdilution method also according to CLSI15. The MBC was deter-
mined in Müller–Hinton Agar (MHA) and bacterial susceptibility was assessed at
17 h. MBC was considered the lowest concentration of compound resulting in
bacterial death (average of at least three independent experiments). A very similar
protocol was used for the time-kill assay, where the incubation was performed with
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the desired starting bacterial population (106, 107, and 108 cells mL−1). Then, at
desired incubation times, aliquots were retrieved, serial diluted, and transferred to
MHA, where the number of colony-forming units (CFU) was determined
(experimental details for MIC, MBC, and time-killing curves are available in Sup-
plementary Methods).
Resistance development. Resistant mutants to the major families of antibiotics
were created using a variant of the gradient-plate methodology59, for the
following antibiotics of diverse classes: erythromycin (macrolide), penicillin,
vancomycin (glycopeptide), ciprofloxacin (quinolone), and tetracycline (Sigma-
Aldrich). The plates were inoculated with 100 µL of 0.5 McFarland bacterial
suspension of B. cereus ATCC 14579 strain, carefully dispersed on the agar surface
using spreading spheres. The plates were incubated at 30 °C during 24 h.
Afterwards, the colony closest to the higher concentration in the gradient was
collected, resuspended and re-inoculated in new fresh gradient plates. This
procedure was repeated for 15 days.
Cytotoxicity. Caco-2 cell culture and viability assays were performed using a pre-
established methodology60. Caco-2 cells (ATCC® HTB-37™), from human color-
ectal adenocarcinoma and tested negative for mycoplasma (MycoAlert™ myco-
plasma detection kit from Lonza Walkersville, Inc.), were grown in Dulbecco’s
modified Eagle’s medium high glucose supplemented with 10% fetal bovine serum,
2 mM glutamine, 100 UmL−1 penicillin, and 100 μg mL−1 streptomycin, in a
humidified incubator at 37 °C with a 5% CO2 atmosphere. The cells were trypsi-
nized twice a week with trypsin/EDTA (0.05%/0.02%) and the medium was also
changed twice a week. Compound antiproliferative effect was performed using the
MTT assay by using 96-well microplates, where 20,000 cells per well were seeded.
After 24 h, compounds were added to the plate in concentrations ranging from 0.1
to 100 μM. In order to evaluate an eventual solvent cytotoxicity, a control with the
used solvent was carried out in all experiments. After the appropriate incubation
time, freshly prepared MTT (0.5 mgmL−1) was added to each well, and the plate
was incubated for 3–4 h in a humidified atmosphere with 5% CO2, at 37 °C. Then,
the MTT supernatant solution was removed and the blue formazan crystals were
dissolved by adding EtOH/dimethyl sulfoxide (1:1) (100 µL). The optical density
was measured at 570 nm and 650 nm on a microplate reader Victor3 (PerkinElmer
Life Sciences).
Preparation of protoplasts and spheroplasts. Bacterial spheroplasts and pro-
toplasts [lipopolysaccharide (LPS) and peptidoglycan-free bacteria] were prepared
by collecting bacterial cells by centrifugation (10,000 × g for 10 min at 4 °C) and
washing with 10 mM Tris-HCl (pH 8) at 4 °C. Cells were resuspended and sup-
plemented with sucrose (0.6 M) at room temperature. Lysozyme (0.5 mg mL−1)
(Sigma-Aldrich) was added, very slowly aiming to decrease the aggregation of
plasts, after 30 min of incubation. The plasts (used at the same concentration as in
the biological activity assay) were incubated with the desired compound and with
polymyxin B as a positive control, at various concentrations.
Morphologic evaluation by AFM. Samples containing B. cereus ATCC 14579 (106
CFUmL−1) in MH medium were incubated with compound 1 at various con-
centrations (0, 8, and 16 µg mL−1) and after 2 h aliquots were taken. A drop (40 µL)
containing the bacteria was deposited onto freshly cleaved mica surfaces for 30
min, gently washed with Milli-Q water, and dried under mild nitrogen flux. The
surface was examined ex situ, at ambient temperature (21 °C), using Nanoscope
IIIa multimode AFM (Digital Instruments, Veeco, Santa Barbara, CA) and etched
silicon tips (TESP-V2, Bruker) with a resonance frequency of ca. 300 kHz. Images
were acquired with scan rates between 1.2 Hz and 1.5 Hz. It is worth to note that
washing and drying steps, as well as tip repetitive scanning did not influence the
results presented in this work.
Differential metabolomics analysis. Bacterial metabolic response to 1 was eval-
uated using Phenotype MicroArrays (Biolog), assessing the metabolism of 95 dif-
ferent carbon sources by B. cereus. PM1 microplates were prepared with PM
inoculating fluid (100 μL), sealed, shielded from light, and incubated at 35 °C with
orbital shaking. Compound 1 (at the final concentration of 16, 8, 4, and 0 μg mL−1)
was added at 1 h of incubation. Bacterial growth was monitored by OD590nm at
time 0 min, at 30 min, at 60 min after incubation, then hourly for 27 h.
Susceptibility of Bacillus spores. Production of spores from B. cereus ATCC
14579 was carried out by incubation at 37 °C in sporulation medium [CCY—
Bacillus t Sporulation media:61 Acid casein hydrolysate (1 g L−1), 1 g L−1 bacto
casitone (pancreatic casein hydrolysate), 0.4 g L−1 yeast extract, 20 mg L−1 L-glu-
tamine, 0.06% (v/v) glycerol, 1.77 g L−1 KH2PO4, 4.53 g L−1 K2HPO4, 0.5 mM
MgCl2.6H2O, 0.01 mM MnCl2.4H2O, 0.05 mM ZnCl2, 0.2 mM CaCl2.6H2O, 0.05
mM FeCl3.6H20] for 96 h. Purification of the spores was achieved by centrifugation
at 4 °C, 15,000 × g and washing 10 times with Milli RO water. For preparation to
the susceptibility assays, the spores were suspended in 1 mM PBS and 0.01% Tween
20, then submitted to heat treatment at 70 °C for 30 min. Germination was
achieved in AGFK buffer (30 mM L-asparagine, 5,6 mM D-Glucose, 5,6 mM D-
Fructose, 20 mM KCl, and 50 mM Tris-HCl, pH 8.4) at 37 °C. Susceptibility to
compound 1 was assessed at all the preparation steps, 20 min and 2 h after the
germination process.
Computational methods. DFT calculations were performed with Gaussian 0962.
All geometry optimizations and subsequent frequency calculations were carried out
with PBE063/6-311 G**64. Solvent effects were accounted by the integral equation
formalism of the polarizable continuum model65 on the electronic density [steered
molecular dynamics (SMD)]66. Molecular mechanics/molecular dynamics (MM/
MD) simulations were performed using GROMACS version 4.0.767. The GROMOS
54A7 force field68 was employed, along with the GROMOS 56ACARBO force field69
to model carbohydrates. All systems were solvated with adequate number of SPC70
water molecules in periodic tetragonal boxes. The simulations were performed in a
constant number, pressure and temperature (NPT) ensemble with temperature and
pressure being kept at 308 K and 1 bar, respectively. The ST simulations were
performed by applying different negative lateral pressure values in the xy plane of
the simulation box. Initial configurations for the membrane pore and glycoside/
phospholipid bilayer simulations were pre-equilibrated, energy minimized and
initialized following stepwise procedures as described in Supplementary Methods,
together with full computational details.
Steady-state fluorescence anisotropy. POPE and 1,2-diacyl-sn-glycero-3-phos-
phoethanolamine from soybean (SoyPE) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA) and Sigma-Aldrich (St. Louis, MO, USA), respectively.
TMA-DPH was purchased from Molecular Probes, Inc. (Eugene, OR, USA).
HEPES buffer contains 10 mM HEPES, 150 mM NaCl, 1 mM EDTA (pH 7.4).
LUVs were extruded with Whatman® nuclepore polycarbonate filters (Sigma-
Aldrich, St. Louis, USA) in a mini-extruder (Avanti Polar Lipids, Alabaster, USA).
Turbidity was measured in a spectrophotometer (Beckam Instruments, Inc.,
Fullerton, USA), whereas steady-state fluorescence anisotropy measurements
were made using a Horiba Jobin Yvon Spex Fluorolog 3-22/Tau 3 spectro-
fluorometer (Kyoto, Japan). MLVs containing 0.4 mol% TMA-DPH were
obtained by co-dissolving the lipids (POPE:soyPE 3:1), probe, and glycoside in
chloroform, followed by solvent evaporation under nitrogen stream and high
vacuum desiccation. Dried lipid films were then hydrated with 10 mM HEPES
buffer (pH 7.4) to the desired final concentration (0.5 mM lipid, and 0/50 μM
glycoside). Lipid suspensions were subjected to five cycles of freezing and thawing
at 25 °C. Anisotropy was measured by exciting samples at 360 nm and collecting
emission at 430 nm, using 2.7 nm slit width. Temperature was maintained with an
isothermal bath and was monitored with a thermistor, inserted into the sample
chamber.
Turbidity measurements. MLVs composed exclusively of 2 mM POPE were
prepared as above and then converted into LUVs by 17 passages through two
stacked 0.1 μm polycarbonate filters in a mini-extruder, at 30 °C. LUVs were
titrated with the compounds 1 or 13 in ethanol, or ethanol (control) and, after 5
min, turbidity was measured with a double beam spectrophotometer, at 35 °C, as
the ratio between the absorbance of LUVs suspension at 450 nm in the presence of
glycoside minus its intrinsic absorbance (A–B), and the absorbance of LUVs in the
presence of the same volume of ethanol (A0). Zero absorbance was set with LUVs,
prior to addition of glycoside.
Membrane leakage assay. The effect of both compounds 1 and 13 on lipid
bilayers passive permeability was assessed by monitoring the leakage of intrali-
posomal carboxyfluorescein, by the increase of its fluorescence intensity over time.
LUVs suspensions composed of POPE or POPC were prepared in Hepes 10 mM,
pH 7.4, containing carboxyfluorescein at a concentration of 40 mM. Non-
encapsulated carboxyfluorescein was separated from the LUVs by ultra-
centrifugation at 150,000 × g for 2 h. After discarding the supernatant, the pellet
containing the vesicles was resuspended in Hepes 50 mM (isosmotic with the
previous buffer), pH 7.4, and centrifuged again at 150,000 × g for 2 h. The
supernatant is rejected and the pellet resuspended in the desired volume of Hepes
50 mM, pH 7.4. The LUVs were then distributed in a 96-well clear bottom
microplate to a final lipid concentration of ~ 0.5 mM and a final volume of 250 μL.
The release of carboxyfluorescein was measured as the variation of fluorescence
intensity at excitation and emission wavelengths of 495 and 535 nm, respectively,
with a cutoff filter at 530 nm, using a microplate reader (Gemini EM Microplate
Reader, Molecular Devices), at 30 ± 1 °C. The fluorescence intensity readings
were performed for ca. 15 min with the LUVs suspension before adding the
compounds to confirm liposome stability. Compounds 1 and 13 were added
from an ethanol stock solution and the same volume of ethanol [1.2 % (v/v)]
was added to the control wells. Finally, Triton X-100 was added to a final
concentration of 0.5% (v/v) to obtain the fluorescence intensity corresponding
to the complete release of carboxyfluorescein. Quantification of leakage was
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determined according to Equation 1:
%Leakage ¼ Ft  F0
F100  F0
ð1Þ
where Ft is the fluorescence value over time after blank subtraction, F0
corresponds to the initial fluorescence of the vesicle suspension, and F100 stands for
the fluorescence value after the addition of Triton X-100. Experimental leakage
curves were fitted with an exponential equation (Equation 2):
L ¼ Lmax 1 exp t=τLð Þ½  ð2Þ
where Lmax stands for the maximum leakage associated to each kinetic constant, t is
the time after the addition of the compound and τL is leakage time.
Monolayer measurements. The interaction of compounds 1 and 13 with phos-
pholipids was also evaluated using lipid monolayers formed at the air–water
interface. A computer-controlled Langmuir trough (Kibron, µTrough G1, Helsinki,
Finland with a resolution of 0.06 mNm−1) was used to record compression iso-
therms (π–A) and ST variation over time of pure POPE and POPC monolayers in
the absence and in the presence of the compounds. All glassware and Langmuir
trough components used were rinsed thoroughly with ethanol and purified water
(Millipore) before each experiment.
Aliquots of lipids in chloroform were spread, drop-by-drop, onto the subphase
(Hepes 10 mM, pH 7.4, 150 mM NaCl). In order to guarantee the complete
evaporation of the solvent, monolayers were let to settle for at least 15 min before
experiment start.
Compression isotherms were obtained for POPC and POPE at 30 ± 1 °C and
stirring in the absence and presence of compound 1 and for POPE also in presence
of 13. Compression isotherms of each monolayer were performed until two
subsequent compression curves overlapped, after which the compounds were
added to the subphase to a maximum compound: lipid ratio of 1:10. Then,
compression curves were acquired until two successive curves superimposed again.
Barrier speed during compression was set to ~ 5 cm2min−1. To further test the
interaction of the compounds with POPE, after an equilibrium π of about 25 mNm
−1 was attained for a preformed POPE monolayer, the variation of surface pressure
(π) was recorded over time upon two successive injections of 0.1 μM of compounds
1 or 13 into the subphase, allowing for equilibration between additions.
For further details, see Supplementary Methods.
Data availability
The authors declare that all data supporting the findings of this study are available within
the paper and its Supplementary Information files, and from the authors upon reasonable
request.
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